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Abstract
Adenoid cystic carcinoma (ADCC) is a pathology aﬀ ecting exocrine glands originating 
primarily from the minor salivary glands. Although rare in incidence, but there are cases of 
seeding of cells of adenoid cystic carcinoma into intracranial sites via diﬀ erent routes. We 
report of an intriguing case of remote metastasis of an intracranial tumor in the pituitary 
diagnosed as pituitary adenoma which spread to the oral cavity as ADCC. According to 
our perspective, it is the fi rst reported case of seeding of cells from intracranial pituitary 
adenoma to intra-oral site manifesting as ADCC.
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Introduction
Adenoid cystic carcinoma (ADCC) is a tumor or pathology 
aﬀ ecting mainly the minor salivary glands, the major salivary 
glands, lacrimal gland, bronchus, breast, and intestinal and 
genital tracts.[1,2] It is characteristically slow growing but often 
invades the cranial base directly with rates of cranial base 
invasion between 4% and 22%.[3] However, intracranial remote 
metastasis from ADCC of the salivary gland is quite rare,[4] but it 
has been reported in the literature.[5] Pituitary adenomas are the 
third most common all primary intracranial tumors. However, 
primary pituitary adenomas metastases into extracranial sites are 
very rare. We report a rare incidence of remote metastasis of an 
intracranial tumor in the pituitary to the oral cavity. According 
to our perspective, it is the fi rst reported case of seeding of cells 
from cephalad to caudad direction.
Case Report
A 69-year-old male patient reported to our department with 
the chief complaint of growth in the right lower back tooth 
region associated with diﬃ  culty in chewing food from that 
side since 6 months. The patient also complained of pain in 
the same region since 6 months. The swelling was initially 
small in size and gradually increased to reach the present size. 
The pain was moderate, intermittent, localized, aggravated 
on chewing food and subsided on its own medical history 
revealed pituitary macroadenoma [Figure 1]. It was diagnosed 
Figure  1: Magnetic resonance imaging depicting pituitary 
macroadenoma on sagital section
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4 years back in a neurosurgical center patient had visited 
due to systemic symptoms. The tumor was surgically treated 
by pituitary decompression via endonasal transsphenoidal 
approach 4 years back and the patient was asymptomatic after 
the surgery [Figure 2]. On intraoral examination a well-defi ned 
erythematous swelling with ill-defi ned borders measuring about 
2 cm × 3 cm in size was seen on the right lower posterior buccal 
mucosa involving the retromolar area and pterygomandibular 
raphe extending into the soft palate [Figure 3]. On palpation, 
the swelling was fi rm in consistency and tender. In light of 
the patients history, and clinical examination, a provisional 
diagnosis of salivary gland neoplasm was given. The lesion was 
excised in toto and sent for histopathological examination, the 
excision site was sutured using the buccal pad of fat which healed 
uneventfully on follow-up [Figure 4]. The patient is under 
follow-up every 3 months, and there has been no recurrence of 
tumor intraorally, also there are no systemic symptoms to prove 
recurrence of intracranial tumors over a period of 2 years.
Histopathological examination of the excised specimen 
revealed stratifi ed squamous epithelium and partially 
encapsulated mass comprising of hypercellular areas. Cells are 
arranged in small nests, cords, islands with tubular, and cribiform 
patterns. The prominently solid pattern was seen. Lobules of 
minor salivary glands were seen at the periphery. Perineural 
invasion was also seen [Figure 5].
The overall histopathological features were diagnostic 
of ADCC. The specimen was further subjected to 
immunofl urosence study in which pituitary tumor transforming 
gene (PTTG) was seen [Figure 6].
Discussion
ADCC is a malignant salivary gland tumor which was fi rst 
described by Billroth in 1859 as cylindroma, due to its 
cribriform appearance formed by the tumor cells with cylindrical 
pseudolumina or pseudospaces.[6,7] The term “ADCC” was 
introduced by Ewing (Foote and Frazell) in 1954. ADCC has 
a rare incidence of <1% of all malignancies of head and neck. It 
represents 5-10% of all salivary gland neoplasms.[8] Intraorally 
50% of ADCCs occur on the palate. The area of the greater 
palatine foramen is more commonly involved in the palate. The 
other less common sites of involvement are a lower lip, buccal 
mucosa, the fl oor of the mouth retromolar area, tonsillar pillar 
area, sublingual gland.[8] The nose and paranasal sinuses are also 
aﬀ ected by ADCCs.[9]
Generally tumors are classifi ed according to the histologic 
pattern that predominates. Szanto et al. graded ADCC as 
cribriform or tubular (Grade I), <30% solid (Grade II) or >30% 
solid (Grade III).[10] Cribriform is the most common and solid 
is the least common. It is seen that mostly ADCCs do not occur 
in “pure” cribriform, tubular or solid types but are rather mixed. 
It is common to have more than one histopathologic pattern 
Figure 2: Post-operative magnetic resonance imaging where no lesion can be seen
Figure 3: Intra-oral growth seen on right side
Figure 4: Post-operative healing aft er 4 weeks
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in a single neoplasm and all three patterns can be observed in 
the majority of tumors. The main reason for histological typing 
is to assess the prognostic diﬀ erence between histologic types. 
In terms of prognosis tubular pattern (well diﬀ erentiated) is 
observed to have the best prognosis compared to the cribriform 
pattern (moderately diﬀ erentiated) and solid pattern (poorly 
diﬀ erentiated).[11] Perineural invasion is characteristic of these 
tumors and occurs in up to 60% of cases.[7] It was also seen in our 
case in the histopathology report.
Furthermore, expression of PTTG has been reported to 
be seen in high rates in pituitary adenomas. This gene also has 
been implicated in the invasiveness of the tumor.[12] It has also 
been reported with ADCC.[13] Our case also showed expression 
of PTTG. It raised suspicion that the adenoid cystic carcinoma 
is not an independent entity but may be due to the seeding of 
the cells of pituitary adenoma to the oral cavity. It prompted 
us to search the available literature for this cephalad to caudad 
spread.
Pituitary adenoma is the most common type of pituitary 
disorder.[14] They are benign neoplasms that account for 10-15% 
of all intracranial masses. Usually detected during the autopsy 
and radiologic studies indicate that the majority of these tumors 
are incidentalomas without clinical signifi cance.[15]
The World Health Organization classifi ed pituitary tumors 
(2000) into the three grades: Benign, intermediate or atypical, 
and malignant.[16] Pituitary adenomas are also categorized 
based on primary cell origin and type of hormone secreted 
by these cells. Tumors are also categorized based on size as 
microadenomas - tumors that are <10 mm in size and are located 
totally within the sella turcica, macroadenomas in turn are large 
tumors (>10 mm), totally intrasellar but are often associated 
with extrasellar extension. Such tumors usually extend inferiorly 
into the sphenoid sinus, but mostly go superiorly into the 
suprasellar space (due to lower resistance) which puts pressure 
on the optic apparatus, or extends into the cavernous sinuses on 
either side.[17]
ADCC is characteristically slow growing but often invades 
the cranial base directly with rates of cranial base invasion 
between 4% and 22%. However, intracranial remote metastasis 
from ADCC of the salivary gland is quite rare. According to 
Shotton et al., cranial base invasion occurs along three routes: 
The eustachian tube, the mandibular and maxillary nerves, and 
the internal carotid artery. There are four metastatic pathways 
to the pituitary gland; (1) Direct blood-borne metastasis to the 
posterior lobe with subsequent expansion, (2) blood-borne 
metastasis to the pituitary stalk with growth into the anterior 
and posterior pituitary lobes, (3) blood-borne metastasis to the 
clivus, dorsum sellae, or cavernous sinus, which then spreads 
into the pituitary gland, and (4) leptomeningeal spread with 
involvement of the pituitary capsule.[5]
The tumor cells can spread to diﬀ erent distant parts which 
usually involve the liver, lymph nodes, bone, and lung and 
unusual places, such as heart, pancreas, eye, ear, ovary, and 
myometrium.[18] In our case, it has spread to the oral cavity. 
The spread pathway of tumor cells from pituitary has not been 
determined but has been proposed to be varied, including 
cerebrospinal fl uid circulation and lymphatic or hematogenous 
metastasis to extracranial sites.[19] The seeding of tumor cells 
can be attributed to the biological properties of tumors, such 
as invasion or to the surgical procedures used. According 
to the existing literature, the metastases of pituitary tumors 
generally occur after surgery to extracranial sites, especially 
after craniotomy. Tanaka et al. reported the development 
of metastases after surgery performed for primary pituitary 
tumors in 21 (70%) of 30 cases.[16] It was felt that surgery may 
precipitate post-operative metastasis of pituitary adenomas. 
According to neurosurgeon’s, this can be due to several reasons. 
First, neurosurgery, especially in craniotomy, there can be a 
rupture of the tumor capsule as well as damage to the normal 
arachnoid membrane, leading to the spread of tumor cells 
along the subarachnoid space. Second, the vasculature around 
the tumor are encroached, which may lead to hematogenous 
spread. Third, tumor cells can also disseminate by the surgical 
Figure 5: Histopathology shows cells are arranged in small nests, 
cords, islands with tubular, and cribiform patterns
Figure  6: Immunofl urosence study shows pituitary tumor 
transforming gene emitting blue color 
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instruments or fl ush water. It is seen that the most patients who 
reported with post-operative metastases of pituitary tumors 
underwent craniotomies before 2000. After 2000, the endonasal 
transsphenoidal surgical technique is done in more than 90% 
of pituitary tumor surgeries. The endonasal transsphenoidal 
approach rarely causes a massive cerebrospinal fl uid leakage or 
tumor cell dissemination to the subarachnoid space, and, as a 
result, the possibility of surgery associated post-operative tumor 
metastasis in the subarachnoid space is reduced,[16] but still 
chances are there as is seen in our case.
Conclusion
Usually, the oral lesion is the fi rst and only symptom of disease 
which might be growing silently elsewhere in the body. A prompt 
diagnosis of such lesions warrants a holistic approach toward the 
systemic investigation. Tumors such as the present case can be 
easily confused with primary salivary gland neoplasm compelling 
the surgeon to focus attention to it while the systemic cause gets 
neglected leading to catastrophic consequences. So though rare, 
metastasis from intracranial pituitary tumors must be considered 
in the diﬀ erential diagnosis of ADCC.
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